The American Journal of Managed Care

Patients With COPD Prefer Improvement of Daily Symptoms Rather Than Exacerbations

A discrete choice experiment found that patients with moderate-to-severe chronic obstructive pulmonary disease (COPD) valued improvement in their daily symptoms more than improvement of exacerbations.
Healthline

COPD: Symptoms and Patient Groups

COPD symptoms vary depending on the amount of lung damage that has occurred due to inhaled substances, most commonly smoking. Symptoms are usually slow to develop and often don’t appear until there’s ...
Healio

Ensifentrine improves dyspnea, symptoms, quality of life in COPD without exacerbations

Please provide your email address to receive an email when new articles are posted on . This analysis focused on adults with moderate to severe COPD without an exacerbation during the ENHANCE trials.
The American Journal of Managed Care

Diagnostic Efficacy of Frequent Acute Exacerbations Investigated in Patients With COPD

Imaging and clinical characteristics reach high diagnostic efficacy when they are used to identify frequent acute exacerbations in patients with chronic obstructive pulmonary disease (COPD). A mix of ...
Medscape

When it Comes to COPD Symptoms, Are Patients What They Eat?

Chronic obstructive pulmonary disease is frequently associated with cardiovascular, metabolic, and psychological diseases, all of which can negatively impact quality of life, exacerbations, and ...
Medscape

Influence of Season on Exacerbation Characteristics in Patients With COPD

This study involved 307 patients with COPD enrolled in the London COPD cohort and included their contributing data from at least 1 year between November 1, 1995, and November 1, 2009. The patients and ...
Reading Eagle

Therapy is available to help control COPD symptoms

COPD, or chronic obstructive pulmonary disease, is a leading cause of disability and death in the U.S., according to the American Lung Association. More than 12.5 million people have been diagnosed ...
PMLive

GSK’s Nucala approved by MHRA for uncontrolled COPD

GlaxoSmithKline’s (GSK) Nucala (mepolizumab) has been approved by the MHRA to treat adults with uncontrolled chronic ...
Healio

Speech features change during onset, peak of COPD exacerbation

Please provide your email address to receive an email when new articles are posted on . Minimum pitch in the morning was significantly higher at exacerbation onset and peak vs. baseline. In the ...
Monthly Prescribing Reference

Ensifentrine Improves Lung Function, Cuts COPD Exacerbations in Late Stage Trial

Credit: Getty Images. Ensifentrine (RPL554) is a first-in-class, dual phosphodiesterase (PDE) 3 and 4 inhibitor with combined bronchodilator and anti-inflammatory actions. Treatment with nebulized ...
Thorax

Mechanisms driving immunopathogenesis of viral exacerbations in chronic respiratory disease

Background Exacerbations are major causes of morbidity in individuals with chronic respiratory diseases such as chronic ...